TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of eligible IBD patients entering trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Radiologic outcomes using regional kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcomes using questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Weight of patients treated with Apremilast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Amount of P. aeruginosa in sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hamilton Depression Rating Scale (HAM-D21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cough frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of New Onset of Diabetes After Transplant (NODAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rating of perceived discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived social support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral and attitudinal support for abstinence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Part II Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in UPDRS Part III Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in 39 Item Parkinson's Disease Questionnaire (PDQ-39) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants With and Without R0 Resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: RMSD of Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RMSD of Respiratory Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6-month Local Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in the HAM-A Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Pain Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Marine Omega-3 Polyunsaturated Fatty Acid Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of medication prescription errors
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Patients With a Complete Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Total Kidney Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Expression of miRNA-452
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of MMP-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post operative sore throat
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of post operative sore throat
Endpoint domain: Adverse events/effects
Primary endpoint: Mean arterial pressure after endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2h iAUC for pp glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2h iAUC for pp insulin response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of females with severe or moderate hemophilia A or B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concentration of cytokines in fracture ankle versus non-fracture ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokines correlation with clinical outcomes (AOFAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute graft-versus-host disease (GVHD)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With a Treatment-Emergent Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Technical Success of the Procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average number of punctures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Psychosocial traits distribution
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale scores for discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale scores for mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual Analogue Scale scores for disability
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Acceptability of HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: myeloid PTP1B expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myeloid PTP1B activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adolescent anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cocaine safety
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with genetic counseling services (Genetic Services Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with genetic counseling services (Remote Counseling Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Procedural motor performance (error and time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Peanut Allergy at 72 Months of Age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antimicrobial activity of silver nanoparticles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in QtracW scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in NCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete metabolic response (CMR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Assessment Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Client Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lymph node yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CRPS incidence
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of All Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of all Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from WOMAC Points at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Exercise Adherence at 12 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Knee Osteoarthritis Exercise Adherence Scale Points at 12 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC and Cmax of Clopidogrel and Digoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinically relevant non-major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of unspecified stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of systemic embolic events
Endpoint domain: Adverse events/effects
Primary endpoint: Neonatal Facial Coding System Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain functions measured by blood oxygen level dependent effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Free From Radical Cystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 2 hours glucose level after OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of correctly identified healthy patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of subjects with undetectable viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pelvic tilt in degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction assessed by the VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fluid responsiveness identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-72) of AZD9291
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of AZD9291
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subclinical thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of patients achieving clinical desensitization to peanut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Greater Than 40% Decrease in Histamine-induced Wheal Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal Irritation
Endpoint domain: Adverse events/effects
Primary endpoint: Orthostatic Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in EGFR Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctDNA change index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic value of glucoCEST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in risk behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of subjects with adverse events (AEs) leading to discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with RVNA titer ≥ 0.5 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean level and Change in Salivary cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean level Prosocial behavior assessed with the Zurich prosocial game
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean level Behavioral carefulness assessed with the children's game, Operation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time free of Invasive MV and alive
Endpoint domain: Mortality/survival
Primary endpoint: Difference in SLP Breath Timing indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in SLP derived Relative Contribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in SLP derived Phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery at discharge
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of recovery post operatively
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Disease progression of DILI
Endpoint domain: Mortality/survival
Primary endpoint: Change in maximum tolerated volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in aggregate symptom score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient perception of change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Incontinence Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertensive disorders of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Distance from CEJ to BD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance between the lower margin of the rectal lesion and anal verge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of low anterior resection syndrome (LARS)
Endpoint domain: Adverse events/effects
Primary endpoint: Size of bowel lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AB680 Peak Plasma Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AB680 Time of Peak Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YMRS (Young Mania Rating Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS (Montgomery-Åsberg Depression Rating Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop out rate
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Ratio of Dose Normalized AUCtau for Bosentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratio of Dose Normalized AUCtau for Sildenafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratio of Dose Normalized Cmax for Bosentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratio of Dose Normalized Cmax for Sildenafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liters of Oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of implants insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in SF36
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: First pass success rate of internal jugular vein catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of colorectal cancer incidence attributable to mutations in known predisposing genes
Endpoint domain: Mortality/survival
Primary endpoint: Time to spontaneous eye opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Central neuropathic pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Maximum Esophageal Eosinophil Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Eosinophils/High Power Field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HFO occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Hot Flash Severity Score (HFSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCINF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Health Questionnaire 9
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in days on mechanical ventilation, renal replacement therapy, or vasopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with EGFR mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STI/HIV infection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cosmetic Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Numerical Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Short physical performance battery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean 10-year risk of CVD event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in NIH Toolbox Fluid Cognition Composite Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: misdiagnosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal voluntary activation of quadriceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: epithelial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smooth muscle density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Postoperative Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of achieving Low Disease Activity (LDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal-to-noise ratio (SNR) of hyperpolarized lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-tumoral C-pyruvate to lactate (kPL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-tumoral C-pyruvate to glutamate (kPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of uninsured persons attending first visit with a health professional
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence rate of achieving adequate surgical resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cough symptom total-score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum Level of Alkaline Phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who have lost response to biotherapies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptom Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: INR change from Day 1 to Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with first-cycle dose limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Day of neutrophil engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Day of platelet engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Evaluation of engraftment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Signal strength measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Respiratory Failure-free Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: total score of the Hamilton Rating Scale for Depression (HAMD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Global sign and symptom score for blepharitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of CBCT imaging with diagnostic mammography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discordance of CBCT imaging with diagnostic mammography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response of Anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area Under the Curve From Time Zero to Extrapolated Infinite Time (AUC Infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Oswestry Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percent of daily off time during the waking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % patients with parenteral nutrition associated cholestasis (PNAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lens Deposits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to exertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with IBD
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of post operative seroma
Endpoint domain: Adverse events/effects
Primary endpoint: reduction in plasma N-terminal pro-B-type natriuretic peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Health Related Quality of Life (HRoQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hormonal levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction of GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: GERD-Health Related Quality of Life (HRQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increase in fetal hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes